JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹839 Cr | ₹77 Cr | ₹-61 Cr | ₹414 Cr | ₹836 Cr |
What is the latest Consolidated Net Profit of JUBILANT PHARMOVA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹839 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹-61 Cr |
| Mar2022 | ₹414 Cr |
| Mar2021 | ₹836 Cr |
How is Consolidated Net Profit of JUBILANT PHARMOVA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹839 Cr | 988.72 | |
| Mar2024 | ₹77 Cr | Positive | |
| Mar2023 | ₹-61 Cr | Negative | |
| Mar2022 | ₹414 Cr | -50.48 | |
| Mar2021 | ₹836 Cr | - | |
Compare Consolidated Net Profit of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹13,801.0 Cr | -3.8% | -11.7% | -8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -3.8% |
-11.7% |
-8.9% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses